KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $2.43.

  • Gilead Sciences' EPS (Weighted Average and Diluted) rose 14300.0% to $2.43 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.45, marking a year-over-year increase of 796250.0%. This contributed to the annual value of $0.38 for FY2024, which is 9144.43% down from last year.
  • Gilead Sciences' EPS (Weighted Average and Diluted) amounted to $2.43 in Q3 2025, which was up 14300.0% from $1.56 recorded in Q2 2025.
  • Gilead Sciences' 5-year EPS (Weighted Average and Diluted) high stood at $2.43 for Q3 2025, and its period low was -$3.34 during Q1 2024.
  • In the last 5 years, Gilead Sciences' EPS (Weighted Average and Diluted) had a median value of $1.21 in 2021 and averaged $0.97.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first skyrocketed by 390000.0% in 2023, then tumbled by 51750.0% in 2024.
  • Gilead Sciences' EPS (Weighted Average and Diluted) (Quarter) stood at $0.3 in 2021, then surged by 336.33% to $1.3 in 2022, then fell by 13.42% to $1.13 in 2023, then grew by 26.15% to $1.42 in 2024, then soared by 71.14% to $2.43 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $2.43 for Q3 2025, versus $1.56 for Q2 2025 and $1.04 for Q1 2025.